Telesis Bio Inc. financial data

Symbol
TBIO on Nasdaq
Industry
Laboratory Analytical Instruments
Location
10431 Wateridge Circle, Suite 150, San Diego, California
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Codex DNA, Inc. (to 10/28/2022)
Latest financial report
Q1 2024 - May 10, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 333 % -19.9%
Quick Ratio 31.4 % +107%
Debt-to-equity 530 % +589%
Return On Equity -480 % -421%
Return On Assets -51.2 % +1.77%
Operating Margin -179 % -12.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 30.1 M shares +1.36%
Common Stock, Shares, Outstanding 1.67 M shares -94.4%
Entity Public Float 14.2 M USD -15.5%
Common Stock, Value, Issued 0 USD -100%
Weighted Average Number of Shares Outstanding, Basic 1.67 M shares +1.4%
Weighted Average Number of Shares Outstanding, Diluted 1.67 M shares +1.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 24.6 M USD -12.4%
Cost of Revenue 9.75 M USD -17.3%
Research and Development Expense 15.3 M USD -31.3%
Selling and Marketing Expense 11.4 M USD -32%
General and Administrative Expense 20.9 M USD -4.53%
Operating Income (Loss) -44.1 M USD +1.13%
Nonoperating Income (Expense) -1.13 M USD +36.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -45.2 M USD +2.49%
Income Tax Expense (Benefit) 23 K USD +9.52%
Net Income (Loss) Attributable to Parent -45.2 M USD +2.49%
Earnings Per Share, Basic -0.41 USD/shares +94.8%
Earnings Per Share, Diluted -0.41 USD/shares +94.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 10.6 M USD -54.5%
Accounts Receivable, after Allowance for Credit Loss, Current 3 M USD -48.6%
Inventory, Net 3.67 M USD +59.9%
Assets, Current 23.4 M USD -45.5%
Operating Lease, Right-of-Use Asset 28.3 M USD +32.5%
Intangible Assets, Net (Excluding Goodwill) 1.24 M USD -29.4%
Goodwill 3.5 M USD -76.5%
Assets 63.3 M USD -29%
Accounts Payable, Current 1.91 M USD -21.9%
Employee-related Liabilities, Current 2.41 M USD -26.9%
Contract with Customer, Liability, Current 375 K USD -87.4%
Liabilities, Current 6.41 M USD -43%
Contract with Customer, Liability, Noncurrent 110 K USD -17.9%
Operating Lease, Liability, Noncurrent 29.8 M USD +40.7%
Liabilities 41.7 M USD -20.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -10 K USD -600%
Retained Earnings (Accumulated Deficit) -170 M USD -36.2%
Stockholders' Equity Attributable to Parent -8.24 M USD -122%
Liabilities and Equity 63.3 M USD -29%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.24 M USD +71%
Net Cash Provided by (Used in) Financing Activities -27 K USD -50%
Net Cash Provided by (Used in) Investing Activities 12.2 M USD +197%
Common Stock, Shares Authorized 100 M shares 0%
Common Stock, Shares, Issued 1.67 M shares -94.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 8.98 M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 10.7 M USD -54.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 162 K USD -68.2%
Deferred Tax Assets, Valuation Allowance 41.8 M USD +42.1%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 49.1 M USD +61%
Operating Lease, Liability 30.7 M USD +40%
Depreciation 1.92 M USD +44.8%
Payments to Acquire Property, Plant, and Equipment 502 K USD +6.81%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -45.3 M USD +2.42%
Lessee, Operating Lease, Liability, to be Paid 47.3 M USD +35.5%
Operating Lease, Liability, Current 879 K USD +17.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.14 M USD +45.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.01 M USD +52.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 16.7 M USD +28.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.16 M USD +52.8%
Deferred Tax Assets, Operating Loss Carryforwards 28.7 M USD +15.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5 M shares
Unrecognized Tax Benefits 338 K USD -23.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.99 M USD +43.7%
Operating Lease, Payments 548 K USD +18.9%
Additional Paid in Capital 162 M USD +0.25%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 515 K USD -2.83%
Deferred Tax Assets, Net of Valuation Allowance 7.31 M USD +580%
Share-based Payment Arrangement, Expense 3.57 M USD -20.3%
Interest Expense 217 K USD -66%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares